Cite
HARVARD Citation
Van de Wyngaert, Z. et al. (2021). Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma. European journal of haematology. pp. 467-472. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Van de Wyngaert, Z. et al. (2021). Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma. European journal of haematology. pp. 467-472. [Online].